It has been nearly a year since OpenAI unleashed ChatGPT on the world, and it seems as if no one (at least in tech) has stopped talking about generative AI since. Meanwhile, the applications of GenAI go way beyond chatbots and copyright-grey-area image ‘artistry’. For instance, Cradle, a biotech software startup out of Delft, Netherlands, is using it to help biologists engineer improved proteins, making it easier and quicker to bring synthetic bio-solutions for human and planetary health to market. In synthetic biology, people use engineering principles to design and build new biological systems. Scientists can use parts of DNA…
This story continues at The Next Web
from The Next Web https://ift.tt/05WAjkq
Comments
Post a Comment